Cision Welcomes Guy Abramo as New Chief Executive Officer

2025-01-15 IDOPRESS

CHICAGO,Jan. 15,2025 --Cision,a leader in consumer and media intelligence solutions,is pleased to announce the appointment of Guy Abramo as its new Chief Executive Officer,effective immediately.


Guy Abramo joins Cision as Chief Executive Officer

Guy brings more than 25 years of executive leadership experience,having driven growth and transformation across diverse industries. Most recently,Guy served as CEO of HireRight,where he led its IPO in 2021 and its take-private transaction in 2024. Prior to this,Guy held leadership roles at Experian,Ingram Micro,Exxon/Mobil,and KPMG Consulting,earning a reputation for innovation and operational excellence.

"Guy's leadership and ability to deliver results make him the ideal choice to lead Cision into its next chapter,"said Brandon Crawley,Managing Director at Platinum Equity,which acquired Cision in 2021. "We are confident that under his guidance,Cision will continue to strengthen its position as a trusted partner to our customers while driving growth and innovation."

Guy holds a Bachelor's degree in Chemical Engineering from NJIT and an MBA from Georgetown University. Based in Las Vegas,he is eager to engage with Cision's global team and customer base.

"Cision is a dynamic company with a strong legacy and an incredible future,"said Guy Abramo,Cision CEO. "I am honored to join this team and look forward to collaborating with employees,customers,and stakeholders to build on our momentum and achieve new milestones together."

About Cision


Cision is a global leader in consumer and media intelligence,engagement,and communication solutions. We equip PR and corporate communications,marketing,and social media professionals with the tools they need to excel in today's data-driven world. Our deep expertise,exclusive data partnerships,and award-winning products,including CisionOne,Brandwatch,and PR Newswire,enable over 75,000 companies and organizations,including 84% of the Fortune 500,to see and be seen,understand and be understood by the audiences that matter most to them.

Contact Information:


For media inquiries,please contact:


Cision Public Relations


CisionPR@cision.com

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map